report that DYRK1A is widely overexpressed among pancreatic adenocarcinomas, resulting in increased production of oncogenic hepatocyte growth factor, and that inhibition of DYRK1A by harmine attenuates the growth of pancreatic adenocarcinoma cells in vitro and in vivo (112). The gene discussed is DYRK1A; the disease is pancreatic adenocarcinoma.